MPS Limited announced that its wholly-owned subsidiary, MPS North America LLC (MPS NA LLC), has secured funding arrangements to partially finance its acquisition of Unbound Medicine, Inc. The total consideration for the acquisition is USD 16.50 Million. The funding will comprise inter-company loans: USD 3.00 Million from American Journal Experts, LLC, and USD 1.94 Million from MPS Limited itself. Additionally, MPS Limited will avail a term loan facility of INR 420.00 million from ICICI Bank Limited, which will be utilized for equity infusion into MPS NA LLC. The company also proposes to infuse equity aggregating to USD 9.81 million into MPS NA LLC, funded through internal accruals and the ICICI Bank term loan. The agreements for these funding arrangements were executed on 04 February 2026. The inter-company loans are unsecured, with interest rates of 3.79% per annum for the loan from American Journal Experts, LLC, and 8.69% per annum for the loan from MPS Limited. The term loan from ICICI Bank Limited has an interest rate of 7.85% per annum and is secured by an exclusive charge over the borrower's current and movable fixed assets. MPS NA LLC will continue to be a wholly-owned subsidiary of MPS Limited post-infusion.
